Overview

Drug-Drug Interaction Study With Rifampin

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine if the concomitant administration of rifampin with BMS-708163 will affect the Pharmacokinetics of BMS-708163 and to assess safety and tolerability of co-administration BMS-708163 and rifampin

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Collaborator:

PRA Health Sciences

Treatments:

Rifampin